Pharma stocks under pressure, tank over 10 per cent as Trump hints at 'never seen before' tariffs

Pharma Companies Likely to See Up to 16 Pc Sales Growth in FY25: Centrum Report

Get latest articles and stories on Business at LatestLY. India's leading pharmaceutical companies are expected to report strong sales growth of up to 16 per cent year-on-year (YoY) in the financial year 2024-25, according to a report by Centrum Institutional Research. Business News | Pharma Companies Likely to See Up to 16 Pc Sales Growth in FY25: Centrum Report.

Pharma stocks under pressure, tank over 10 per cent as Trump hints at 'never seen before' tariffs

Cipla Share Price, Sun Pharma Share Price: Shares of pharmaceutical companies are under pressure on Friday, i.e. April 4, 2025, after US President Donald Trump said that the sector will see 'never seen before' tariffs. As a result, the Nifty Pharma index fell over 6 per cent after opening in the green today. Nifty Pharma had started the session in green at 21,430.95 against the previous close of 21,423.55.  Following the US President's remark, s…

Stock Market Highlights: Trump tariff exemption boosts pharma but Nifty muted, ends below 23,300

Share Market Highlight | BSE Sensex, Nifty 50 Today: Indian equity markets slipped during Thursday's trade after Trump announced 26% tariffs on foreign imports to the US.

Pharma stocks saw a rise on Thursday, but crashed badly on Friday Indian Share Market (Aaj Samaj), Business Desk: US President Donald Trump is always known for his sensational statements. He often surprises the world with his statements. Currently, the sector that is being affected the most by Trump's statements is the economy of many countries. Trump gives some sensational statement every day regarding America's new tariff policy. The effect of…

Pharma's Growth (Or Lack Thereof) On Digital Platforms

Pharmaceutical advertising on TV is being questioned by the Trump Administration, but the industry's ads aren't just limited to television. Data from MediaRadar, recently published in a TripleLift report – The Future of TV Advertising Under RFK – details how pharma brands have grown or shrunk budgets on digital platforms year-over-year.The MediaRadar data states that pharma brands spent $7.9 billion on advertising from Jan.-Oct. 2024, which was …

Trump hints at separate tariffs: Will pharma sector take a hit?

New Delhi: Shares of Indian pharmaceutical companies, including Aurobindo Pharma, Laurus Labs, IPCA Laboratories, and Lupin have fallen by as much as 8% on Friday after comments from U.S. President Donald Trump, who said that tariffs on the sector were approaching. Speaking to the media, Trump said that his administration was contemplating possible tariffs on pharmaceuticals. Indicating that trade measures would be coming he said, “Pharma is goi…